Indexed by Science Citation Index (SciSearch), International Pharmaceutical Abstract, Chemical Abstracts, Embase, Index Copernicus, EBSCO, African Index Medicus, JournalSeek, Journal Citation Reports/Science Edition, Directory of Open Access Journals (DOAJ), African Journal Online, Bioline International, Open-J-Gate

ISSN: 1596-5996 (print); 1596-9827 (electronic)-


Home | Back Issues | Current Issue | Review manuscript | Submit manuscript

 
 

This Article

 

Abstract

 

Full-Text (PDF)

 

Table of contents

 

Comments

 

Letters

 

Comments to Editor

 

e-mail Alert

 

Sign Up

 

Research Article


 

Development and Validation of a Dissolution Test Method for Artemether and Lumefantrine in Tablets

 

P Umapathi1*,  J Ayyappan2 and S Darlin Quine3    

1Department of Analytical Research and Development, Micro Labs Ltd, 67/68-A, Third Phase, Peenya Industrial Area, Bangalore 560 058, 2SASTRA University, Thanjavur, Tamil Nadu, 3PG and Research Department of Chemistry, Government Arts College, Chidambaram, India

 

For correspondence: E-mail: umpy04@yahoo.com  Tel: +91-80-28379197
 

Received: 5 March 2011                                                   Revised accepted: 6 September 2011

 

Tropical Journal of Pharmaceutical Research, Oct 2011; 10(5): 643-653

http://dx.doi.org/10.4314/tjpr.v10i5.14

  

Abstract

 

Purpose: To develop and validate a dissolution test method for dissolution release of artemether and lumefantrine  from tablets.

Methods: A single dissolution method for evaluating the in vitro release of artemether and lumefantrine from tablets was developed and validated. The method comprised of a dissolution medium of 1000 ml of 2 %w/v of Myrj 52  in 0.005M HCl per vessel with the paddle rotating at 100 rpm for 120 min. The dissolution samples were analysed using a Waters HPLC system with Waters symmetry column (C-18 column of 250mm x 4.6mm i.d., 5 µ particle size). The mobile phase was a mixture of 20 volumes of 0.5 %v/v of triethylamine in water (adjusted to a pH of 3.0 with orthophosphoric acid) and 80 volumes of acetonitrile. The detection wavelength was set at 216 nm and 100 µl of each sample was injected. The HPLC method used for the determination of drug release was validated for the parameters of accuracy, precision, linearity, specificity, filter validation, solution stability and robustness.

Results: The dissolution test provided sink conditions for artemether and lumefantrine and was able to discriminate between tablet formulations of different hardness and different composition. Application of Mann-Whitney U test for significant difference between samples at various time points during the dissolution test yielded z values > 1.96 (1.96 = critical z value at p = 0.05)  for the various formulations tested, indicating the discriminatory power of the dissolution test.

Conclusion: This validated dissolution test may be used as a single dissolution test for artemether and luminfantrine in tablet formulations.

 

Keywords: Artemether, Lumefantrine, Tablet formulations, Single dissolution test, HPLC.

Copyright@2002-2010. Pharmacotherapy Group, Faculty of Pharmacy, University of Benin, Benin City. All rights reserved.

Powered by Poracom E-mail: jmanager@poracom.net